Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 923 

    Article Cited by others


Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis

Dogan Zeynal, Filik Levent, Ergül Bilal, Sarikaya Murat

Year : 2015| Volume: 21| Issue : 6 | Page no: 396-399

   This article has been cited by
1 Clinical impact and mechanisms in hepatitis B virus infection concurrent with non-alcoholic fatty liver disease
Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li
Chinese Medical Journal. 2022; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
2 Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?
Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan
Liver International. 2020; 40(3): 496
[Pubmed]  [Google Scholar] [DOI]
3 Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients
Jie Li, An K. Le, Kevin T. Chaung, Linda Henry, Joseph K. Hoang, Ramsey Cheung, Mindie H. Nguyen
Liver International. 2020; 40(5): 1052
[Pubmed]  [Google Scholar] [DOI]


Read this article